Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
112.69
+0.59 (+0.53%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
37
38
Next >
7 Blue-Chip Stocks to Buy on the Dip
October 19, 2023
While you can find plenty of ideas swimming in red ink, investors may find greater success with blue-chip stocks to buy on the dip.
Via
InvestorPlace
These Analysts Cut Their Forecasts On Abbott After Q3 Results
October 19, 2023
Abbott Laboratories (NYSE: ABT) reported better-than-expected third-quarter results.
Via
Benzinga
Expert Ratings for Abbott Laboratories
October 19, 2023
Via
Benzinga
Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript
October 18, 2023
ABT earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Abbott Laboratories (NYSE: ABT) Highlighted for Surprising Price Action
October 18, 2023
Via
Investor Brand Network
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday
October 18, 2023
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Abbott Raises Outlook, Boosted By 'Whopping' Growth Of Diabetes Device
October 18, 2023
The company raised the midpoint of its earnings outlook.
Via
Investor's Business Daily
Abbott Laboratories's Earnings Outlook
October 17, 2023
Via
Benzinga
A Look Into Abbott Laboratories Inc's Price Over Earnings
October 16, 2023
Via
Benzinga
Abbott Stock Gains On Q3 Performance, 10% Organic Diagnostics Revenue Growth, Raised Annual Outlook
October 18, 2023
Abbott Laboratories (NYSE: ABT) has reported Q3 FY23 adjusted EPS of $1.14, almost similar to $1.15 a year ago, beating the con
Via
Benzinga
Oversold and Overextended, Abbott Laboratories is a Great Buy
October 18, 2023
Abbott Laboratories rises on solid results and guidance; the value and dividend are at the best levels in years, and the sell-side is buying.
Via
MarketBeat
Exposures
COVID-19
US Stocks Set For Weak Open Ahead Of Tesla Q3 Print: Why This Analyst Is Skeptical Of S&P 500 Recovery To Early 2022 High
October 18, 2023
U.S. stocks faced another setback on Wednesday due to uncertainty surrounding interest rates and inflation.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns
October 16, 2023
Via
Benzinga
Topics
ETFs
Abbott Laboratories Unusual Options Activity For October 12
October 12, 2023
Via
Benzinga
3 Reasons to Buy Abbott Laboratories Stock
October 11, 2023
Don't just focus on the recent past.
Via
The Motley Fool
Earnings Scheduled For October 18, 2023
October 18, 2023
Companies Reporting Before The Bell • Procter & Gamble (NYSE:PG) is expected to report quarterly earnings at $1.71 per share on revenue of $21.67 billion.
Via
Benzinga
Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate
October 16, 2023
(Monday market open) Last week gave us a taste of earnings. The meal starts tomorrow and picks up steam as banks, airlines, and health care companies report.
Via
Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
October 06, 2023
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $2,900 Today
October 05, 2023
Via
Benzinga
Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar?
October 16, 2023
While analysts look forward to the unfolding reporting season with guarded optimism, they are skeptical regarding forward guidance.
Via
Benzinga
3 Dividend Growth Stocks You Can Buy and Hold Forever
October 14, 2023
Investors can sit back and let the dividends flow in with these great stocks.
Via
The Motley Fool
Over Delivering: Big Banks Beat Expectations After Tough Quarter, But Market Eyes Middle East Warily
October 13, 2023
(Friday market open) Big bank earnings this morning threatened to take a back seat as geopolitical worries helped spark a rally in crude oil and sent more investors fleeing toward the perceived safety...
Via
Benzinga
Exposures
Fossil Fuels
Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets
October 13, 2023
Higher-than-expected inflation data this week caught markets off guard, and the Israel-Hamas conflict is sending the markets running to safer assets.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
As Isreal-Palestine Conflict Escalates, Gold Ticks Up - ETF Winners And Losers: Medium-Cap Returns
October 12, 2023
Via
Benzinga
Topics
ETFs
Why Medtronic And Abbott Stocks Are Sinking
October 11, 2023
Medtronic plc. (NYSE: MDT) and Abbott Laboratories (NYSE: ABT) shares are trading lower on Wednesday after the U.S.
Via
Benzinga
Abbott Laboratories Explores Consumer Wearables Market As COVID Testing Sales Dwindle: CEO
October 11, 2023
Abbott Laboratories (NYSE: ABT) CEO Robert Ford, while speaking at the HLTH conference in Las Vegas, outlined the company's strategic move into the consumer wearables market.
Via
Benzinga
Exposures
COVID-19
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
October 11, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair.
Via
Benzinga
3 Dividend Kings Every Investor Should Own to Survive a Market Crash
October 10, 2023
Dividend stocks that raise their payout beat all other kinds of stocks, making Dividend Kings the best stocks to buy in a downturn.
Via
InvestorPlace
Lumentum Lights Up on the AI and ML Surge
October 10, 2023
Optical and photonics manufacturer Lumentum Holdings Inc. (NASDAQ: LITE) provides optical components and lasers to data centers, cloud providers, telecoms
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October
October 09, 2023
These two healthcare stocks are reliable passive income vehicles.
Via
The Motley Fool
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.